Results for &quot;&quot;Basiliximab&quot;&quot;[mesh_terms]

Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses.

Tamiris A Miranda, Claudia R Felipe, Renato H N Santos, Jose O Medina Pestana, Helio Tedesco-Silva Junior

Therapeutic drug monitoring 2021;42(6):811-820

Does basiliximab induction trigger lifethreatening ARDS and shock in young patients after kidney transplantation?

Annick Massart, Sarah Heenen, Gilbert Bejjani, Anh Dung Hoang, Dimitri Mikhalski, Emine Broeders, Jacques Creteur, Daniel De Backer, Daniel Abramowicz

Clinical nephrology 2015;83(1):61-70

Immunomodulation, Acute Renal Failure, and Complications of Basiliximab Use After Liver Transplantation: Analysis of 114 Patients and Literature Review.

E C de Ataide, S R Perales, J B Bortoto, M A O Peres, F C Filho, R S B Stucchi, E Udo, I F S F Boin

Transplantation proceedings 2018;49(4):852-857

Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients.

A Asberg, A Hartmann, E Fjeldså, S Bergan, H Holdaas

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2002;1(4):382-6

Early steroid withdrawal in pediatric renal transplant on newer immunosuppressive drugs.

Angela Delucchi, Marcela Valenzuela, Mario Ferrario, Ana Maria Lillo, J Luis Guerrero, Eugenio Rodriguez, Francisco Cano, Gabriel Cavada, Jorge Godoy, Jorge Rodriguez, C Gloria Gonzalez, Erwin Buckel, Luis Contreras

Pediatric transplantation 2008;11(7):743-8

Prospective controlled protocol for three months steroid withdrawal with tacrolimus, basiliximab, and mycophenolate mofetil in renal transplant recipients.

Ji Hye Kim, Jong Hoon Lee, Su Jin Kim, Chang-Kwon Oh

Journal of Korean medical science 2012;27(4):337-42

Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data.

Nicholas J A Webb, Sylwester Prokurat, Karel Vondrak, Alan R Watson, David A Hughes, Stephen D Marks, Nadeem E Moghal, Maggie M Fitzpatrick, David V Milford, Moin A Saleem, Caroline A Jones, Styrbjorn Friman, Rita Van Damme-Lombaerts, Francoise Janssen, Clare Hamer, Sarah Rhodes

Pediatric nephrology (Berlin, Germany) 2009;24(1):177-82

Current status of immunosuppressive agents for solid organ transplantation in children.

Anil Dhawan, Tracy Coelho, Michael Tredger

Pediatric transplantation 2012;16(2):106-22

A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT.

Armin D Goralczyk, Andreas Schnitzbauer, Tung Y Tsui, Giuliano Ramadori, Thomas Lorf, Aiman Obed

BMC surgery 2010;10():15

The renal-sparing efficacy of basiliximab in adult living donor liver transplantation.

Chih-Che Lin, Feng-Rong Chuang, Chih-Hsiung Lee, Chih-Chi Wang, Yaw-Sen Chen, Yueh-Wei Liu, Bruno Jawan, Chao-Long Chen

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;11(10):1258-64

Enteric-coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients.

Steve Chadban, Josette Eris, Graeme Russ, Scott Campbell, Jeremy Chapman, Bruce Pussell, Paul Trevillian, Francesco Ierino, Napier Thomson, Brian Hutchison, Ashley Irish, Chad Woodcock, Nicol Kurstjens, Rowan Walker

Nephrology (Carlton, Vic.) 2013;18(1):63-70

Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients.

Diane Cibrik, Herwig-Ulf Meier-Kriesche, Barbara Bresnahan, You Min Wu, Goran Klintmalm, Clifton E Kew, Paul C Kuo, John Whelchel, David Cohen, Prabakar Baliga, Enver Akalin, Enrico Benedetti, Francis Wright, Bonnie Lieberman, Bettina Ulbricht, Stephen Jensik

Clinical transplantation 2007;21(2):192-201

Everolimus plus reduced-exposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients.

H Tedesco Silva, D Cibrik, T Johnston, E Lackova, K Mange, C Panis, R Walker, Z Wang, G Zibari, Y S Kim

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010;10(6):1401-13

One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.

Giovanni Montini, Luisa Murer, Luciana Ghio, Beatrice Pietrobon, Fabrizio Ginevri, Mariano Ferraresso, Massimo Cardillo, Mario Scalamogna, Francesco Perfumo, Alberto Edefonti, Giovanni Franco Zanon, Graziella Zacchello

Transplant international : official journal of the European Society for Organ Transplantation 2005;18(1):36-42